Advance Search
WANG Yichao, ZHANG Yan. Effect of endovascular interventional therapy combined with recombinant tissue plasminogen activator on arterial thrombolysis in patients with acute cerebral infarction[J]. Journal of Clinical Medicine in Practice, 2020, 24(3): 16-18. DOI: 10.7619/jcmp.202003005
Citation: WANG Yichao, ZHANG Yan. Effect of endovascular interventional therapy combined with recombinant tissue plasminogen activator on arterial thrombolysis in patients with acute cerebral infarction[J]. Journal of Clinical Medicine in Practice, 2020, 24(3): 16-18. DOI: 10.7619/jcmp.202003005
shu

Effect of endovascular interventional therapy combined with recombinant tissue plasminogen activator on arterial thrombolysis in patients with acute cerebral infarction

  • 1. Department of Neurology, Hanzhong People's Hospital, Hanzhong, Shaanxi, 723000;

  • 2. The Second Department of Encephalopathy, Baoji Traditional Chinese Medicine Hospital in Jintai District of Baoji City, Baoji, Shaanxi, 721001

More Information
  • Received Date: November 19, 2019
    Graphical Abstract
    • Abstract
  • Objective To investigate the clinical effect of intravascular interventional therapy combined with recombinant tissue plasminogen activator(r-TPA)on arterial thrombolysis in patients with acute cerebral infarction. Methods A total of 120 patients with acute cerebral infarction treated in our hospital were selected and divided into control group(n=60)and observation group(n=60)according to the digital parity method, the former group used r-TPA arterial thrombolysis, while the latter group was combined with intravascular interventional therapy. Vascular recanalization rate, National Institutes of Health Stroke Scale(NIHSS)score and daily living ability between the two groups were compared. Results The complete recanalization rate of blood vessels in the observation group was higher, and the re-occlusion rate of the blood vessels was lower than that in the control group(P < 0.05). The NIHSS score was(3.24±0.61)points at 2 weeks after operation in the observation group, which was lower than(6.74±0.82)points of the control group; the daily living ability score was(89.35 ± 8.35)points at 4 weeks after operation in the observation group, which was higher than(75.26±8.14)points of the control group, the differences were statistically significant(P < 0.05). The incidence of bleeding events of the two groups showed no significant differences(P > 0.05). Conclusion Intravascular interventional therapy combined with recombinant tissue plasminogen activator can obtain ideal results, which can increase the recanalization rate and reduce the bleeding rate.
    • FullText(HTML)
    • References (17)
  • Zhao J H, Wang B, Wang X H, et al. Effect of lncRNA GAS5 on the apoptosis of neurons via the notch1 signaling pathway in rats with cerebral infarction[J]. Eur Rev Med Pharmacol Sci, 2019, 23(22): 10083-10091.
    韩凝, 张帆, 郜利会, 等. 头颅MRI对急性颅内大动脉梗死动脉溶栓患者的筛选价值[J]. 河北医科大学学报, 2016, 37(9): 1076-1079.
    高海东, 崔敏玲, 马海龙, 等. 动静脉联合应用重组组织型纤溶酶原激活剂治疗超时间窗急性脑梗死患者近期预后影响因素分析[J]. 贵州医药, 2019, 43(7): 1090-1091.
    罗韶辉, 王玉凯, 杜朴, 等. 经颅多普勒超声持续监测辅助阿替普酶动脉溶栓治疗急性脑梗死的疗效观察[J]. 中国医师进修杂志, 2016, 39(12): 1068-1071.
    曹志红, 智孔亮, 卢丽敏, 等. 机械溶栓结合尿激酶治疗急性脑梗死的疗效观察[J]. 中西医结合心脑血管病杂志, 2016, 14(20): 2435-2437.
    中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国急性缺血性脑卒中诊治指南2018[J]. 中华神经科杂志, 2018, 51(9): 666-682.
    蔡必扬, 郭洪权, 李华. 关于美国国立卫生研究院卒中量表翻译的警示[J]. 中华神经科杂志, 2017, 50(9): 712-712.
    江志滨, 卢峰, 李波, 等. 阿加曲班配合高压氧对老年缺血性脑卒中患者的Barthel指数、神经认知功能评分及血液流变学的影响[J]. 医学研究杂志, 2016, 45(7): 138-141.
    周龙江, 王苇, 刘振生, 等. Gateway球囊碎栓联合动脉内溶栓治疗复杂颅内及颈动脉系统急性闭塞1例[J]. 中华放射学杂志, 2016, 50(11): 896-897.
    董琨, 李明达. 支架机械取栓治疗急性大脑中动脉栓塞的临床疗效与长期预后观察[J]. 山东医药, 2017, 57(46): 89-91.
    Kristian P, Cholevík D, CzernýD. Selective angiography with the possibility of thrombolysis in patients with central retinal artery occlusion[J]. Cesk Slov Oftalmol, 2019, 75(3): 152-159.
    傅攀, 朱碧宏. 机械辅助动脉溶栓联合脑心通胶囊治疗急性缺血性脑卒中的临床疗效研究[J]. 医学研究杂志, 2016, 45(3): 146-149.
    姜大景, 胡婷婷, 汪华, 等. 多模式CT指导下静脉和动脉溶栓治疗急性脑梗死的效果和安全性比较[J]. 中国CT和MRI杂志, 2016, 14(3): 38-40.
    Boyd S, Shah V, Belik J. A novel role for milrinone in neonatal acute limb ischaemia: successful conservative treatment of thrombotic arterial occlusion without thrombolysis[J]. BMJ Case Rep, 2019, 12(12): e232440.
    谭文刚. 血管内机械取栓治疗急性脑梗死疗效观察[J]. 新乡医学院学报, 2019, 36(1): 85-88.
    张萍, 张永巍, 吴涛, 等. 静脉溶栓联合血管内治疗对急性中重症脑梗死患者预后的影响因素分析[J]. 中国脑血管病杂志, 2016, 13(7): 343-347.
    王以翠, 常焕显, 孔令胜, 等. 重组组织型纤溶酶原激活剂动脉溶栓联合血管内治疗对早期脑梗死患者的疗效观察[J]. 中国急救医学, 2016, 36(7): 609-613.
    • Related Articles

  • Related Articles

    [1]LI Jun, ZHANG Xizhi, QIAN Jiewei, ZHANG Xianwen, GUI Longgang, BAI Zhenglu, HOU Xiaoxiao, CHEN Xuemei. Dosimetric study of optimum treatment mode applied in intensity-modulated radiotherapy for postoperative rectal cancer[J]. Journal of Clinical Medicine in Practice, 2023, 27(9): 13-19, 38. DOI: 10.7619/jcmp.20230419
    [2]LI Ruibiao, REN Chengbo, WANG Cong, LI Yaru. Comparison of the efficacy of dosimetric parameters defined by different lung volume methods in predicting radiation pneumonitis in patients with non-small cell lung cancer[J]. Journal of Clinical Medicine in Practice, 2022, 26(19): 5-8, 13. DOI: 10.7619/jcmp.20221246
    [3]YUAN Meifang, YANG Yi, SUN Mengzhen, WEN Xiaobo, ZHAO Biao. Study on thyroid radiation dose of two intensity-modulated radiotherapy plans after radical mastectomy of left breast cancer[J]. Journal of Clinical Medicine in Practice, 2021, 25(24): 16-19. DOI: 10.7619/jcmp.20213277
    [4]ZHOU Hui, SHAN Shucan. Dosimetry and passing rate of forward-intensity modulated radiation therapy and intensity modulated radiation therapy for left breast cancer patients with breast conserving surgery[J]. Journal of Clinical Medicine in Practice, 2021, 25(1): 15-18. DOI: 10.7619/jcmp.20200319
    [5]PAN Xiang, YANG Yi, HOU Yu, YUAN Meifang. Dosimetric differences of different radiation modes based on Monaco in postoperative intensity modulated radiotherapy of patients with left breast-conserving surgery for breast cancer[J]. Journal of Clinical Medicine in Practice, 2021, 25(1): 1-5. DOI: 10.7619/jcmp.20200621
    [6]YUAN Meifang, ZHAO Biao, YANG Yi, TANG Kewei, AN Yijun. Static intensity-modulated radiotherapy versus volumetric modulated arc therapy in dosimetric parameters of target area and organs at risk for middle thoracic esophageal cancer[J]. Journal of Clinical Medicine in Practice, 2020, 24(15): 21-24. DOI: 10.7619/jcmp.202015006
    [7]PAN Xiang, LI Ya, ZHU Sijin, YANG Yi. Dosimetry difference between field-in-field intensity modulated radiation therapy and fixed field inversely optimized intensity modulated radiation therapy in whole brain radiotherapy[J]. Journal of Clinical Medicine in Practice, 2019, 23(19): 12-16. DOI: 10.7619/jcmp.201919003
    [8]AN Xuehong, CAO Hekui, DUAN Shuhao. Effect of spiral fault fixed field intensity modulated radiation therapy on esophageal cancer in middle segment[J]. Journal of Clinical Medicine in Practice, 2018, (11): 101-103. DOI: 10.7619/jcmp.201811028
    [9]LU Yuting, WANG Jian, LIN Tao, SUI Jianfeng, YU Jingping, NI Xinye, SUN Suping. Dosimetry comparison between two different supraclavicular areas irradiation schedules for post-operation breast cancer and its influence on life quality[J]. Journal of Clinical Medicine in Practice, 2016, (19): 34-36. DOI: 10.7619/jcmp.201619010
    [10]ZOU Qinzhou, WEI Xianding, ZHAO Yutian, ZHANG Fuzheng, YANG Bo. Irradiation of the chest wall and regional nodes as an integrated volume with IMRT for breast cancer after mastectomy:from dosimetry to clinical observation[J]. Journal of Clinical Medicine in Practice, 2012, (23): 32-35.

  • Cited by

    Periodical cited type(18)

    1. 唐琪. 依帕司他联合甲钴胺治疗2型糖尿病周围神经病变的效果. 中外医学研究. 2024(09): 136-139 .
    2. 陈丽媛，林富祥，韦春姣. 依帕司他片+硫辛酸注射液治疗糖尿病周围神经病变的临床效果. 糖尿病新世界. 2024(07): 183-186 .
    3. 李志健. 依帕司他联合胰激肽原酶治疗糖尿病周围神经病变患者的效果. 中国民康医学. 2024(14): 28-30 .
    4. 褚桂克，王凡. 益气养血通痹汤联合甲钴胺注射液治疗糖尿病周围神经病变的疗效及对神经传导速度的影响. 中医研究. 2023(04): 40-44 .
    5. 赵媛媛，高烨，钱光芳. 甲钴胺与丹参多酚酸盐联合治疗糖尿病周围神经病变的效果研究. 糖尿病新世界. 2023(10): 187-190 .
    6. 李彬彬，王民，田勇，楚清锋. 依帕司他联合α-硫辛酸治疗老年糖尿病周围神经病变的临床效果. 实用临床医学. 2022(02): 16-19 .
    7. 尹永锋，李江涛，王润青. 依帕司他与α-硫辛酸分别联合甲钴胺治疗对糖尿病周围神经病变患者氧化应激及神经电生理的影响. 河南医学研究. 2022(06): 1103-1106 .
    8. 王璇. 甲钴胺联合依帕司他治疗糖尿病周围神经病变的效果. 中国实用医药. 2022(15): 152-154 .
    9. 李江敏子，刘殿池，尚菊菊，李景，林玥坤，韩强，张红升. 温经散寒法联合甲钴胺治疗糖尿病周围神经病变的疗效及对血清胱抑素C水平的影响. 中国临床研究. 2022(07): 932-937 .
    10. 徐子奇，于鑫淼，任丽媛. 依帕司他联合甲钴胺治疗糖尿病周围神经病变的疗效. 中国现代药物应用. 2022(17): 154-156 .
    11. 刘锦凤，许凯斯，何燕. 依帕司他片联合二甲双胍治疗糖尿病周围神经病变的疗效分析. 中国处方药. 2022(11): 89-91 .
    12. 康宝清，蔡栋立，洪玮莉. 参芪降糖颗粒治疗糖尿病周围神经病变的临床效果及安全性分析. 糖尿病新世界. 2022(22): 66-69 .
    13. 美娜·斯拉木江，李娜，张明珠，阿衣古丽·阿孜提哈孜. 苍柏逐瘀汤治疗糖尿病周围神经病变痰瘀阻络证临床观察. 山西中医. 2021(04): 19-21+24 .
    14. 谭永华，谭永兰，陈士建. 甲钴胺、依帕司他联合神经血管治疗仪治疗糖尿病周围神经病变的临床效果. 中外医学研究. 2021(21): 51-53 .
    15. 王秀阁，倪青，庞国明. 糖尿病周围神经病变病证结合诊疗指南. 中医杂志. 2021(18): 1648-1656 .
    16. 刘天洋，叶奎. 痛性糖尿病周围神经病药物治疗进展. 中国城乡企业卫生. 2021(12): 45-47 .
    17. 杜凌超，茹志成，孙蕾，陈鹤华. 依帕司他联合硫辛酸治疗糖尿病周围神经病变的临床效果. 慢性病学杂志. 2021(12): 1826-1828+1832 .
    18. 陈晓娟. 血栓通联合依帕司他与甲钴胺在糖尿病周围神经病变中的应用及对神经传导功能的影响. 糖尿病新世界. 2021(21): 195-198 .

    Other cited types(5)

Catalog

    Get Citation
    PDF
    XML
    Article views (340) PDF downloads (9) Cited by(23)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    © 2020 《实用临床医药杂志》编辑部

    Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    Supported by: Beijing Renhe Information Technology Co., Ltd.   Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return